Researchers test a drug or treatment in a small group of people (20-80) for the 1st time
The purpose is to study the drug or treatment to learn about safety and identifying side effects
Phase 2
The new drug or treatment is given to a larger group of people (100-300) to determine its effectiveness and to further study its safety
Phase 3
The new drug/treatment is given to large groups of people (1,000-3,000)
Determines its effectiveness, Monitors side effects, compare it with similar & standard treatments, collect information that will allow it to be used safely
Phase 4
After a drug is approved by the FDA & made available to the public researchers track its safety in the general population
Seeking more information about a drug or treatment’s benefits and optimal use
Addressing the Placebo Fear
A factor that is off-putting for many patients to try clinical trials is the understanding of the placebo treatment.
Many patients don’t consider clinical trials for the fear of receiving no treatment. The “fear” of the placebo.
However, in the vast majority of Brain Cancer clinical trials, the placebo used is actually the standard care of treatment.